Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 1, 2005, Pages 329-342

  Sethi, Charanjit S ^a,c   Lewis, Geoffrey P ^b   Fisher, Steven K ^b   Leitner, William P ^b   Mann, Derrick L ^b   Luthert, Philip J ^a   Charteris, David G ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CALBINDIN; CD68 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; L CONE OPSIN; M CONE OPSIN; NEUROMODULIN; OPSIN; PROTEIN KINASE C; S CONE OPSIN; UNCLASSIFIED DRUG; VIMENTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTE; CELL MEMBRANE; CELL STRUCTURE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITE; DISEASE SEVERITY; FEMALE; GLIA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL PLASTICITY; NERVE ENDING; NERVE FIBER; NEUROFILAMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RETINA AMACRINE CELL; RETINA BIPOLAR GANGLION CELL; RETINA DETACHMENT; RETINA PIGMENT DEGENERATION; RETINA RELAXING SURGERY; RETINA SURGERY; SCORING SYSTEM; SYNAPTIC MEMBRANE; TISSUE FIXATION; UPREGULATION; VITREORETINOPATHY;

ADOLESCENT; ADULT; AGED; APOPTOSIS; BIOLOGICAL MARKERS; EYE PROTEINS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MALE; MICROSCOPY, CONFOCAL; MIDDLE AGED; NEUROGLIA; NEURONAL PLASTICITY; NEURONS; PRESYNAPTIC TERMINALS; RETINAL DETACHMENT; VITREORETINOPATHY, PROLIFERATIVE;

EID: 11144270601     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0518     Document Type: Article

References (93)

1. Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 1991;112:159-165.
2. Weller M, Wiedemann P, Heimann K. Proliferative vitreoretinopathy: is it anything more than wound healing at the wrong place? Int Ophthalmol. 1990;14:105-117.
3. Mietz H, Kirchhof B, Heimann K. Anterior proliferative vitreoretinopathy in trauma and complicated retinal detachment: a histopathologic study. Ger J Ophthalmol. 1994;3:15-18.
4. Erickson PA, Fisher SK, Guerin CJ, Anderson DH, Kaska DD. Glial fibrillary acidic protein increases in Müller cells after retinal detachment. Exp Eye Res. 1987;44:37-48.
5. Lewis GP, Linberg KA, Fisher SK. Neurite outgrowth from bipolar and horizontal cells after experimental retinal detachment. Invest Ophthalmol Vis Sci. 1998;39:424-434.
6. Cook B, Lewis GP, Fisher SK, Adler R. Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci. 1995;36:990-996.
7. Pow DV, Robinson SR. Glutamate in some retinal neurons is derived solely from glia. Neuroscience. 1994;60:355-366.
8. Meyer RL, Miotke JA, Benowitz LI. Injury induced expression of growth-associated protein-43 in adult mouse retinal ganglion cells in vitro. Neuroscience. 1994;63:591-602.
9. Lewis GP, Charterte DG, Sethi CS, Leitner WP, Linberg KA, Fisher SK. The ability of rapid retinal reattachment to stop or reverse the cellular and molecular events initiated by detachment. Invest Ophthalmol Vis Sci. 2002;43:2412-2420.
10. Charterte DG, Sethi CS, Lewis GP, Fisher SK. Proliferative vitreoretinopathy: developments in adjunctive treatment and retinal pathology. Eye. 2002;16:369-374.
11. Asaria RH, Kon CH, Bunce C, et al. Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy: results from a randomized, double-blind, controlled clinical trial. Ophthalmology. 2001;108:1179-1183.
12. Wiedemann P, Hilgers RD, Bauer P, Heimann K. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol. 1998;126:550-559.
13. Lewis H, Aaberg TM. Causes of failure after repeat vitreoretinal surgery for recurrent proliferative vitreoretinopathy. Am J Ophthalmol. 1991;111:15-19.
14. Lewis H, Aaberg TM, Abrams GW. Causes of failure after initial vitreoretinal surgery for severe proliferative vitreoretinopathy. Am J Ophthalmol. 1991;111:8-14.
15. Erickson PA, Fisher SK, Anderson DH, Stern WH, Borgula GA. Retinal detachment in the cat: the outer nuclear and outer plexiform layers. Invest Ophthalmol Vis Sci. 1983;24:927-942.
16. Anderson DH, Stern WH, Fisher SK, Erickson PA, Borgula GA. Retinal detachment in the cat: the pigment epithelial-photoreceptor interface. Invest Ophthalmol Vis Sci. 1983;24:906-926.
17. Sakai T, Lewis GP, Linberg KA, Fisher SK. The ability of hyperoxia to limit the effects of experimental detachment in cone-dominated retina. Invest Ophthalmol Vis Sci. 2001;42:3264-3273.
18. Hagimura N, Suto K, Iida T, Kishi S. Optical coherence tomography of the neurosensory retina in rhegmatogenous retinal detachment. Am J Ophthalmol. 2000;129:186-190.
19. Federman JL, Eagle RC Jr. Extensive peripheral retinectomy combined with posterior 360 degrees retinotomy for retinal reattachment in advanced proliferative vitreoretinopathy cases. Ophthalmology. 1990;97:1305-1320.
20. Alturki WA, Peyman GA, Paris CL, Blinder KJ, Desai UR, Nelson NC Jr. Posterior relaxing retinotomies: analysis of anatomic and visual results. Ophthalmic Surg. 1992;23:685-688.
21. Okada M, Matsumura M, Ogino N, Honda Y. Müller cells in detached human retina express glial fibrillary acidic protein and vimentin. Graefes Arch Clin Exp Ophthalmol. 1990;228:467-474.
22. Guerin CJ, Anderson DH, Fisher SK. Changes in intermediate filament immunolabeling occur in response to retinal detachment and reattachment in primates (published correction appears in Invest Ophthalmol Vis Sci. 1990;31:2360). Invest Ophthalmol Vis Sci. 1990;31:1474-1482.
23. Guerin CJ, Anderson DH, Fisher SK. Changes in intermediate filament immunolabeling occur in response to retinal detachment and reattachment in primates (published correction appears in Invest Ophthalmol Vis Sci. 1990;31:2360). Invest Ophthalmol Vis Sci. 1990;31:1474-1482.
24. Lewis GP, Guerin CJ, Anderson DH, Matsumoto B, Fisher SK. Rapid changes in the expression of glial cell proteins caused by experimental retinal detachment. Am J Ophthalmol. 1994;118:368-376.
25. Lewis GP, Matsumoto B, Fisher SK. Changes in the organization and expression of cytoskeletal proteins during retinal degeneration induced by retinal detachment. Invest Ophthalmol Vis Sci. 1995;36:2404-2416.
26. Lewis GP, Fisher SK. Müller cell outgrowth after retinal detachment: association with cone photoreceptors. Invest Ophthalmol Vis Sci. 2000;41:1542-1545.
27. Fisher SK, Erickson PA, Lewis GP, Anderson DH. Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci. 1991;32:1739-1748.
28. Geller SF, Lewis GP, Anderson DH, Fisher SK. Use of the MIB-1 antibody for detecting proliferating cells in the retina. Invest Ophthalmol Vis Sci. 1995;36:737-744.
29. Dusart I, Marty S, Peschanski M. Glial changes following an excitotoxic lesion in the CNS. II. Astrocytes. Neuroscience. 1991;45:541-549.
30. Fisher SK, Anderson DH. Cellular effects of retinal detachment on the neural retina and the retinal pigment epithelium. In: Ryan S, ed. Retina. 3rd ed. St. Louis: Mosby; 2001:1961-1986.
31. Marc RE, Murry RF, Fisher SK, Linberg KA, Lewis GP. Amino acid signatures in the detached cat retina. Invest Ophthalmol Vis Sci. 1998;39:1694-1702.
32. Marc RE, Murry RF, Fisher SK, Linberg KA, Lewis GP, Kalloniatis M. Amino acid signatures in the normal cat retina. Invest Ophthalmol Vis Sci. 1998;39:1685-1693.
33. Lewis G, Mervin K, Valter K, et al. Limiting the proliferation and reactivity of retinal Müller cells during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol. 1999;128:165-172.
34. Laqua H, Machemer R. Glial cell proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80:602-618.
35. Erickson PA, Guerin CJ, Fisher SK. Tritiated uridine labeling of the retina: changes after retinal detachment. Exp Eye Res. 1990;51:153-158.
36. Hiscott P, Sheridan C, Magee RM, Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res. 1999;18:167-190.
37. Grisanti S, Guidry C. Transdifferentiation of retinal pigment epithelial cells from epithelial to mesenchymal phenotype. Invest Ophthalmol Vis Sci. 1995;36:391-405.
38. McLeod D, Hiscott PS, Grierson I. Age-related cellular proliferation at the vitreoretinal juncture. Eye. 1987;1:263-281.
39. Daicker B, Guggenheim R, Gywat L. Findings on the retinal surface by scanning electron microscopy. III. Epivascular glial clusters (in German). Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977;204:31-37.
40. Kishi S, Numaga T, Yoneya S, Yamazaki S. Epivascular glia and paravascular holes in normal human retina. Graefes Arch Clin Exp Ophthalmol. 1986;224:124-130.
41. Foos RY. Vitreoretinal juncture over retinal vessels. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1977;204:223-234.
42. Chang CJ, Lai WW, Edward DP, Tso MO. Apoptotic photoreceptor cell death after traumatic retinal detachment in humans. Arch Ophthalmol. 1995;113:880-886.
43. Hisatomi T, Sakamoto T, Goto Y, et al. Critical role of photoreceptor apoptosis in functional damage after retinal detachment. Curr Eye Res. 2002;24:161-172.
44. Fariss RN, Molday RS, Fisher SK, Matsumoto B. Evidence from normal and degenerating photoreceptors that two outer segment integral membrane proteins have separate transport pathways. J Comp Neurol. 1997;387:148-156.
45. Nir I, Papermaster DS. Immunocytochemical localization of opsin in the inner segment and ciliary plasma membrane of photoreceptors in retinas of rds mutant mice. Invest Ophthalmol Vis Sci. 1986;27:836-840.
46. Usukura J, Bok D. Changes in the localization and content of opsin during retinal development in the rds mutant mouse: immunocytochemistry and immunoassay. Exp Eye Res. 1987;45:501-515.
47. Lewis GP, Erickson PA, Anderson DH, Fisher SK. Opsin distribution and protein incorporation in photoreceptors after experimental retinal detachment. Exp Eye Res. 1991;53:629-640.
48. Mervin K, Valter K, Maslim J, Lewis G, Fisher S, Stone J. Limiting photoreceptor death and deconstruction during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol. 1999;128:155-164.
49. Lewis GP, Linberg KA, Geller SF, Guerin CJ, Fisher SK. Effects of the neurotrophin brain-derived neurotrophic factor in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci. 1999;40:1530-1544.
50. Rex TS, Fariss RN, Lewis GP, Linberg KA, Sokal I, Fisher SK. A survey of molecular expression by photoreceptors after experimental retinal detachment. Invest Ophthalmol Vis Sci. 2002;43:1234-1247.
51. Linberg KA, Lewis GP, Shaaw C, Rex TS, Fisher SK. Distribution of S- and M-cones in normal and experimentally detached cat retina. J Comp Neurol. 2001;430:343-356.
52. Kroll AJ. Secondary retinal detachment: electron microscopy of retina and pigment epithelium. Am J Ophthalmol. 1969;68:223-237.
53. Mohand-Said S, Hicks D, Leveulard T, Picaud S, Porto F, Sahel JA. Rod-cone interactions: developmental and clinical significance. Prog Retin Eye Res. 2001;20:451-467.
54. Hicks D, Sahel J. The implications of rod-dependent cone survival for basic and clinical research. Invest Ophthalmol Vis Sci. 1999;40:3071-3074.
55. Fariss RN, Li ZY, Milam AH. Abnormalities in rod photoreceptors, amacrine cells, and horizontal cells in human retinas with retinitis pigmentosa. Am J Ophthalmol. 2000;129:215-223.
56. Li ZY, Kljavin IJ, Milam AH. Rod photoreceptor neurite sprouting in retinitis pigmentosa. J Neurosci. 1995;15:5429-5438.
57. Chong NH, Alexander RA, Barnett KC, Bird AC, Luthert PJ. An immunohistochemical study of an autosomal dominant feline rod/cone dysplasia (Rdy cats). Exp Eye Res. 1999;68:51-57.
58. Sanyal S, Hawkins RK, Jansen HG, Zeilmaker GH. Compensatory synaptic growth in the rod terminals as a sequel to partial photo-receptor cell loss in the retina of chimaeric mice. Development. 1992;114:797-803.
59. Chu Y, Humphrey MF, Constable IJ. Horizontal cells of the normal and dystrophic rat retina: a wholemount study using immunolabelling for the 28-kDa calcium-binding protein. Exp Eye Res. 1993;57:141-148.
60. Wen R, Song Y, Cheng T, et al. Injury-induced upregulation of bFGF and CNTF mRNAs in the rat retina. J Neurosci. 1995;15:7377-7385.
61. Li ZY, Chang JH, Milam AH. A gradient of basic fibroblast growth factor in rod photoreceptors in the normal human retina. Vis Neurosci. 1997;14:671-679.
62. Lewis GP, Fisher SK, Anderson DH. Fate of biotinylated basic fibroblast growth factor in the retina following intravitreal injection. Exp Eye Res. 1996;62:309-324.
63. Kivela T, Tarkkanen A, Virtanen I. Intermediate filaments in the human retina and retinoblastoma: an immunohistochemical study of vimentin, glial fibrillary acidic protein, and neurofilaments. Invest Ophthalmol Vis Sci. 1986;27:1075-1084.
64. Ramoa AS, Campbell G, Shatz CJ. Dendritic growth and remodeling of cat retinal ganglion cells during fetal and postnatal development. J Neurosci. 1988;8:4239-4261.
65. Lei JL, Lau KC, So KF, Cho EY, Tay D. Morphological plasticity of axotomized retinal ganglion cells following intravitreal transplantation of a peripheral nerve segment. J Neurocytol. 1995;24:497-506.
66. Eysel UT, Peichl L, Wassle H. Dendritic plasticity in the early postnatal feline retina: quantitative characteristics and sensitive period. J Comp Neurol. 1985;242:134-145.
67. Shen Y, Mani S, Donovan SL, Schwob JE, Meiri KF. Growth-associated protein-43 is required for commissural axon guidance in the developing vertebrate nervous system. J Neurosci. 2002;22:239-247.
68. Baekelandt V, Eysel UT, Orban GA, Vandesande F. Long-term effects of retinal lesions on growth-associated protein 43 (GAP-43) expression in the visual system of adult cats. Neurosci Lett. 1996;208:113-116.
69. Kapfhammer JP, Christ F, Schwab ME. The expression of GAP-43 and synaptophysin in the developing rat retina. Brain Res Dev Brain Res. 1994;80:251-260.
70. Coblentz FE, Radeke MJ, Lewis GP, Fisher SK. Evidence that ganglion cells react to retinal detachment. Exp Eye Res. 2003;76:333-342.
71. Geller SF, Lewis GP, Fisher SK. FGFR1, signaling, and AP-1 expression after retinal detachment: reactive Müller and RPE cells. Invest Opbtbalmol Vis Sci. 2001;42:1303-1369.
72. Heidinger V, Hicks D, Sahel J, Dreyfus H. Ability of retinal Müller glial cells to protect neurons against excitotoxicity in vitro depends upon maturation and neuron-glial interactions. Glia. 1999;25:229-339.
73. Newman EA, Zahs KR. Modulation of neuronal activity by glial cells in the retina. J Neurosci. 1998;18:4022-4028.
74. Ripps H, Witkovsky P. Neuron-glial interaction in the brain and retina. Prog Retin Eye Res. 1985;4:181-219.
75. Wahlin KJ, Campochiaro PA, Zack DJ, Adler R. Neurotrophic factors cause activation of intracellular signaling pathways in Müller cells and other cells of the inner retina, but not photoreceptors. Invest Ophthalmol Vis Sci. 2000;41:927-936.
76. Honjo M, Tanihara H, Kido N, Inatani M, Okazaki K, Honda Y. Expression of ciliary neurotrophic factor activated by retinal Müller cells in eyes with NMDA- and kainic acid-induced neuronal death. Invest Ophthalmol Vis Sci. 2000;41:552-560.
77. Oku H, Ikeda T, Honma Y, et al. Gene expression of neurotrophins and their high-affinity Trk receptors in cultured human Müller cells. Ophthalmic Res. 2002;34:38-42.
78. Frasson M, Picaud S, Leveillard T, et al. Glial cell line-derived neurotrophic factor induces histologic and functional protection of rod photoreceptors in the rd/rd mouse. Invest Ophthalmol Vis Sci. 1999;40:2724-2734.
79. Francke M, Makarov F, Kacza J, et al. Retinal pigment epithelium melanin granules are phagocytosed by Müller glial cells in experimental retinal detachment. J Neurocytol. 2001;30:131-136.
80. Kljavin IJ, Reh TA. Müller cells are a preferred substrate for in vitro neunte extension by rod photoreceptor cells. J Neurosci. 1991;11:2985-2994.
81. Drazba J, Lemmon V. The role of cell adhesion molecules in neurite outgrowth on Müller cells. Dev Biol. 1990;138:82-93.
82. Anderson DH, Guerin CJ, Erickson PA, Stern WH, Fisher SK. Morphological recovery in the reattached retina. Invest Ophthalmol Vis Sci. 1986;27:168-183.
83. Burton TC. Recovery of visual acuity after retinal detachment involving the macula. Trans Am Ophthalmol Soc. 1982;80:475-497.
84. Ross WH. Visual recovery after macula-off retinal detachment. Eye. 2002;16:440-6.
85. Hassan TS, Sarrafizadeh R, Ruby AJ, Garretson BR, Kuczynski B, Williams GA. The effect of duration of macular detachment on results after the scleral buckle repair of primary, macula-off retinal detachments. Ophthalmology. 2002;109:146-152.
86. Cardillo JA, Stout JT, LaBree L, et al. Post-traumatic proliferative vitreoretinopathy: the epidemiologic profile, onset, risk factors, and visual outcome. Ophthalmology. 1997;104:1166-1173.
87. Chisholm IA, McClure E, Foulds WS. Functional recovery of the retina after retinal detachment. Trans Ophthalmol Soc UK. 1975;95:167-172.
88. Chang SD, Kim IT. Long-term visual recovery after scleral buckling procedure of rhegmatogenous retinal detachment involving the macula. Kor J Ophthalmol. 2000;14:20-26.
89. Guerin CJ, Lewis GP, Fisher SK, Anderson DH. Recovery of photoreceptor outer segment length and analysis of membrane assembly rates in regenerating primate photoreceptor outer segments. Invest Ophthalmol Vis Sci. 1993;34:175-183.
90. Miller B, Miller H, Patterson R, Ryan SJ. Retinal wound healing: cellular activity at the vitreoretinal interface. Arch Ophthalmol. 1986;104:281-285.
91. Charteris DG. Growth factors in proliferative vitreoretinopathy (Editorial). Br J Ophthalmol. 1998;82:106.
92. Kon CH, Occleston NL, Aylward GW, Khaw PT. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest Ophthalmol Vis Sci. 1999;40:705-712.
93. Lewis GP, Charteris DG, Sethi CS, Fisher SK. Animal models of retinal detachment and reattachment: identifying cellular events that may affect visual recovery. Eye. 2002;16:375-387.